ArticleBiochimica et biophysica acta. Molecular basis of disease2020

RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.

Brittany Haynes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.